Aizon — Series C · $20M

Aizon closed a $20M Series C led by growth-equity firm NewVale Capital, with existing backers Atlantic Bridge, Crosslink Capital and Uncork Capital participating. The company said the money would scale its AI SaaS platform for GxP pharma manufacturing and fund the launch of its next-generation electronic batch record (eBR) product; the round brought total funding to roughly $44.7M.

LeadNewVale Capital RoundSeries C Announced8 Feb 2024 CitySan Francisco SectorHealthtech & Bio · Pharma manufacturing software Source B P

Something wrong? Suggest a correction →